If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiageo Regulatory News (DGE)

Share Price Information for Diageo (DGE)

Share Price is delayed by 15 minutes
Get Live Data
1,509.00    -55.50 (-3.55%)
Bid:
1,505.00
Ask:
1,505.50
Spread: 0.50 (0.033%)
Market Cap: £33.55b
DGE Live PriceLast checked at - London Stock Exchange

Intraday Diageo Share Chart

Diageo commences new share buy-back programme

12 Oct 2023 07:00

RNS Number : 8433P
Diageo PLC
12 October 2023

Diageo commences new share buy-back programme

12 October 2023: Diageo plc (Diageo) today announces the commencement of its new share buy-back programme, as announced in Diageo's preliminary results for the fiscal year ended 30 June 2023. This share buy-back programme will return up to $1.0 billion of capital to shareholders and is to be completed before the end of fiscal 24.

Diageo is announcing today that it has entered into a non-discretionary agreement with Merrill Lynch International to enable the company to buy-back shares with an aggregate value of up to $1.0 billion (net of any fees payable to or by Merrill Lynch International under the terms of the agreement). This agreement will commence on 12 October 2023 and will end no later than 26 June 2024. The purpose of the new share buy-back programme is to reduce the share capital of Diageo plc. All shares repurchased under this agreement will be cancelled.

The launch of this new programme follows the successful completion of Diageo's additional return of capital programme during the second half of fiscal 23 that ended on 2 June 2023, in which £0.5 billion of capital was returned to shareholders.

Further details of the return of capital programme

Merrill Lynch International will make its trading decisions in relation to Diageo's securities independently of and uninfluenced by Diageo. Any repurchase of shares by Diageo contemplated by this announcement will be carried out on the London Stock Exchange and/or other recognised investment exchange(s).

The share buy-backs will be effected within certain pre-set parameters and in accordance with Diageo's general authority to repurchase shares and will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and, in the case of Diageo, Chapter 12 of the Listing Rules.

This share buyback programme, under which up to $1.0 billion of shares will be repurchased, will occur within the limitations of Diageo's existing general authority to repurchase up to 224,704,974 shares granted at its 2023 Annual General Meeting. For the avoidance of doubt, no repurchases will be made in the United States of America or in respect of Diageo's American Depositary Receipts.

For further information please contact:

Investor relations:

Durga Doraisamy +44 (0) 7902 126 906

Andy Ryan +44 (0) 7803 854 842

Brian Shipman +1 (0) 917 710 3007

investor.relations@diageo.com

Media relations:

Claire Cavana +44 (0) 7751 742 072

Isabel Batchelor +44 (0) 7731 988 857

press@diageo.com

About Diageo

Diageo is a global leader in beverage alcohol with an outstanding collection of brands across spirits and beer categories. These brands include Johnnie Walker, Crown Royal, J&B and Buchanan's whiskies, Smirnoff, Cîroc and Ketel One vodkas, Captain Morgan, Baileys, Don Julio, Tanqueray and Guinness.

Diageo is a global company, and our products are sold in more than 180 countries around the world. The company is listed on both the London Stock Exchange (DGE) and the New York Stock Exchange (DEO). For more information about Diageo, our people, our brands, and performance, visit us at www.diageo.com. Visit Diageo's global responsible drinking resource, www.DRINKiQ.com for information, initiatives, and ways to share best practice.

Celebrating life, every day, everywhere.

Diageo plc LEI: 213800ZVIELEA55JMJ32

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCBLBDGBSBDGXB
Date   Source Headline
3rd Jul 20261:57 pmRNSDirector/PDMR Shareholding
1st Jul 20261:53 pmRNSTotal Voting Rights
18th Jun 202611:30 amRNSDirector/PDMR Shareholding
15th Jun 20264:59 pmRNSDirector/PDMR Shareholding
15th Jun 20264:36 pmRNSDirector/PDMR Shareholding
11th Jun 20261:56 pmRNSDirector/PDMR Shareholding
10th Jun 20265:15 pmRNSDirector/PDMR Shareholding
1st Jun 202611:38 amRNSTotal Voting Rights
21st May 20267:22 amRNSSterling equivalent of Interim Dividend
19th May 20261:08 pmRNSDirector/PDMR Shareholding
18th May 20261:33 pmRNSDirector/PDMR Shareholding
15th May 20262:19 pmRNSDirector/PDMR Shareholding
11th May 20265:07 pmRNSDirector/PDMR Shareholding
11th May 20263:30 pmRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSDiageo issues fiscal 26 Q3 trading statement
1st May 20262:13 pmRNSTotal Voting Rights
20th Apr 20264:49 pmRNSDirector/PDMR Shareholding
17th Apr 20264:39 pmRNSHolding(s) in Company
14th Apr 20269:52 amRNSDirector/PDMR Shareholding
10th Apr 20264:37 pmRNSDirector/PDMR Shareholding
1st Apr 202611:48 amRNSTotal Voting Rights
25th Mar 20267:00 amRNSDiageo subsidiary USL announces divesture in RCB
20th Mar 20263:29 pmRNSDirector/PDMR Shareholding
17th Mar 20263:00 pmRNSDirector/PDMR Shareholding
12th Mar 20265:35 pmRNSPublication of Supplement to Base Prospectus
10th Mar 20266:06 pmRNSDirector/PDMR Shareholding
10th Mar 20263:38 pmRNSDirector/PDMR Shareholding
10th Mar 202612:05 pmRNSDirector/PDMR Shareholding
10th Mar 202612:05 pmRNSDirector/PDMR Shareholding
2nd Mar 202612:55 pmRNSTotal Voting Rights
25th Feb 20267:00 amRNSInterim Results
19th Feb 20265:50 pmRNSDirector/PDMR Shareholding
13th Feb 20268:23 amRNSDirector Declaration
10th Feb 20266:03 pmRNSDirector/PDMR Shareholding
10th Feb 20261:53 pmRNSDirector/PDMR Shareholding
2nd Feb 20262:26 pmRNSTotal Voting Rights
21st Jan 20265:24 pmRNSDirector/PDMR Shareholding
20th Jan 20264:08 pmRNSDirector/PDMR Shareholding
20th Jan 20269:06 amRNSDirector Declaration
16th Jan 20269:31 amRNSDirector/PDMR Shareholding
16th Jan 20269:27 amRNSDirector/PDMR Shareholding
13th Jan 20264:44 pmRNSDirector/PDMR Shareholding
12th Jan 202611:54 amRNSDirector/PDMR Shareholding
5th Jan 20262:31 pmRNSBlock listing Interim Review
5th Jan 20262:26 pmRNSTotal Voting Rights
5th Jan 20268:30 amRNSDirector/PDMR Shareholding
19th Dec 202510:43 amRNSDirector/PDMR Shareholding
19th Dec 202510:43 amRNSDirector/PDMR Shareholding
17th Dec 20254:03 pmRNSDirector/PDMR Shareholding
17th Dec 20254:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.